To strengthen the treatment of genitourinary syndrome of menopause in breast cancer patients
10.3760/cma.j.issn.1674-6090.2019.05.001
- VernacularTitle:关注乳腺癌患者围绝经期泌尿生殖综合征的处理
- Author:
Lingquan KONG
1
;
Jiashuo LIU
;
Hao LI
;
Hongyuan LI
;
Guosheng REN
;
Kainan WU
Author Information
1. 重庆医科大学附属第一医院内分泌乳腺外科 400016
- Keywords:
Breast cancer;
Genitourinary syndrome of menopause;
Vulvovaginal atrophy;
Chemotherapy-induced amenorrhea
- From:
Chinese Journal of Endocrine Surgery
2019;13(5):353-356
- CountryChina
- Language:Chinese
-
Abstract:
Genitourinary syndrome of menopause (GSM),is a common disease in postmenopausal women.It is reported that the incidence of GSM in breast cancer patients (79％-95％) was higher than that in normal counterparts (more than 50％).GSM significantly reduced the quality of life in breast cancer patients,but was not given enough attention,and most of breast cancer patients with GSM were not diagnosed and treated.In addition,chemotherapy and endocrine therapy for breast cancer may increase the incidence and severity of GSM.Hence,prevention and treatment of GSM should be strengthened in breast cancer patients.
